TY  - JOUR
AU  - Fernandez, Oscar
PY  - 2017
DO  - 10.1016/j.msard.2017.07.003
UR  - http://hdl.handle.net/10668/11710
T2  - Multiple sclerosis and related disorders
AB  - Aggressive, highly active, or rapidly evolving severe relapsing-remitting multiple sclerosis (RRMS) is characterized by frequent relapses and active disease on magnetic resonance imaging, ultimately leading to a high risk for rapid disability...
LA  - en
PB  - Elsevier
KW  - Disease-modifying therapy
KW  - High-efficacy disease-modifying therapy
KW  - High-risk multiple sclerosis
KW  - Relapsing-remitting multiple sclerosis
KW  - Alemtuzumab
KW  - Antineoplastic Agents
KW  - Clinical Trials as Topic
KW  - Cyclophosphamide
KW  - Disease Progression
KW  - Fingolimod Hydrochloride
KW  - Humans
KW  - Immunologic Factors
KW  - Immunosuppressive Agents
KW  - Mitoxantrone
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - Natalizumab
KW  - Precision Medicine
KW  - Risk Assessment
KW  - Risk Factors
KW  - Treatment Outcome
TI  - Is there a change of paradigm towards more effective treatment early in the course of apparent high-risk MS?
TY  - research article
VL  - 17
ER  -